4.6 Article

Vaspin - a link of obesity and psoriasis?

Related references

Note: Only part of the references are listed.
Article Dermatology

The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity

Wolf-Henning Boehncke et al.

EXPERIMENTAL DERMATOLOGY (2011)

Review Medicine, General & Internal

Comorbidities in Patients with Psoriasis

Alice B. Gottlieb et al.

AMERICAN JOURNAL OF MEDICINE (2009)

Review Medicine, Research & Experimental

A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity

Q. Li et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)

Article Endocrinology & Metabolism

Serum vaspin concentrations in human obesity and type 2 diabetes

Byung-Soo You et al.

DIABETES (2008)

Review Rheumatology

Adipokines as emerging mediators of immune response and inflammation

Francisca Lago et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)

Article Biotechnology & Applied Microbiology

Large-scale identification of human genes implicated in epidermal barrier function

Eve Toulza et al.

GENOME BIOLOGY (2007)

Article Dermatology

Psoriasis and the metabolic syndrome

Amon D. Cohen et al.

ACTA DERMATO-VENEREOLOGICA (2007)

Article Dermatology

Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis

Dorothea M. Sommer et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2006)

Article Biochemistry & Molecular Biology

Vaspin gene expression in human adipose tissue:: Association with obesity and type 2 diabetes

N Klöting et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Multidisciplinary Sciences

Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity

K Hida et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)